Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing.
作者信息
Allyse Megan, Michie Marsha
机构信息
Center for Biomedical Ethics, 1215 Welch Road, Modular A, Stanford, CA 94305, USA.
出版信息
Trends Biotechnol. 2013 Aug;31(8):439-41. doi: 10.1016/j.tibtech.2013.04.006. Epub 2013 May 9.
Abstract
摘要
相似文献
1
Not-so-incidental findings: the ACMG recommendations on the reporting of incidental findings in clinical whole genome and whole exome sequencing.非偶然发现：美国医学遗传学与基因组学学会关于临床全基因组和全外显子组测序中偶然发现报告的建议
Trends Biotechnol. 2013 Aug;31(8):439-41. doi: 10.1016/j.tibtech.2013.04.006. Epub 2013 May 9.
2
On the justifiability of ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.关于美国医学遗传学与基因组学学会（ACMG）对临床外显子组和基因组测序中偶然发现报告的建议的合理性
J Law Med Ethics. 2015 Spring;43(1):134-42. doi: 10.1111/jlme.12201.
3
Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review.从基因组和外显子组测序数据中发现的具有医学意义的偶然发现的频率和处理方法：系统评价。
Physiol Genomics. 2021 Sep 1;53(9):373-384. doi: 10.1152/physiolgenomics.00025.2021. Epub 2021 Jul 12.
4
Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.临床测序探索性研究联盟中九个实验室对ACMG-AMP变异解读指南的执行情况。
Am J Hum Genet. 2016 Jun 2;98(6):1067-1076. doi: 10.1016/j.ajhg.2016.03.024. Epub 2016 May 12.
5
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.ACMG 临床外显子组和基因组测序中偶然发现报告的推荐标准。
Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20.
6
Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing.最小化 ACMG 建议中报告临床外显子组和基因组测序偶然发现的责任风险。
Genet Med. 2013 Dec;15(12):915-20. doi: 10.1038/gim.2013.135. Epub 2013 Sep 12.
7
Towards a European consensus for reporting incidental findings during clinical NGS testing.达成关于临床二代测序检测中偶然发现报告的欧洲共识。
Eur J Hum Genet. 2015 Dec;23(12):1601-6. doi: 10.1038/ejhg.2015.111. Epub 2015 Jun 3.
8
Genomic test validation for incidental findings.偶然发现的基因组检测验证
Clin Chem. 2014 Feb;60(2):292-3. doi: 10.1373/clinchem.2013.210609. Epub 2013 Jul 1.
9
Reporting Incidental Findings in Clinical Whole Exome Sequencing: Incorporation of the 2013 ACMG Recommendations into Current Practices of Genetic Counseling.临床全外显子组测序中偶发发现的报告：将2013年美国医学遗传学与基因组学学会（ACMG）的建议纳入当前遗传咨询实践
J Genet Couns. 2015 Aug;24(4):654-62. doi: 10.1007/s10897-014-9794-4. Epub 2014 Nov 18.
10
Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.用于检测遗传性疾病中胚系变异的临床全外显子组和全基因组测序的开发与验证
Arch Pathol Lab Med. 2017 Jun;141(6):798-805. doi: 10.5858/arpa.2016-0622-RA. Epub 2017 Mar 31.
引用本文的文献
1
Certain vs. uncertain actionable secondary findings in a cohort of 500 Lebanese participants: What to report to the patient?500名黎巴嫩参与者队列中确定性与不确定性可采取行动的次要发现：该向患者报告什么？
PLoS One. 2025 Jul 18;20(7):e0327471. doi: 10.1371/journal.pone.0327471. eCollection 2025.
2
Exploring the motivations of research participants who chose not to learn medically actionable secondary genetic findings about themselves.探讨选择不了解自身具有医学可采取的二级遗传发现的研究参与者的动机。
Genet Med. 2021 Dec;23(12):2281-2288. doi: 10.1038/s41436-021-01271-1. Epub 2021 Jul 29.
3
Why genomics researchers are sometimes morally required to hunt for secondary findings.为什么基因组学研究人员有时在道德上需要寻找次要发现。
BMC Med Ethics. 2020 Jan 31;21(1):11. doi: 10.1186/s12910-020-0449-8.
4
Ethical Issues in Newborn Sequencing Research: The Case Study of BabySeq.新生儿测序研究中的伦理问题：以 BabySeq 为例。
Pediatrics. 2019 Dec;144(6). doi: 10.1542/peds.2019-1031. Epub 2019 Nov 12.
5
Secondary actionable findings identified by exome sequencing: expected impact on the organisation of care from the study of 700 consecutive tests.外显子组测序识别的次要可操作发现：700 次连续检测研究对护理组织的预期影响。
Eur J Hum Genet. 2019 Aug;27(8):1197-1214. doi: 10.1038/s41431-019-0384-7. Epub 2019 Apr 24.
6
Translating genomics to the clinical diagnosis of disorders/differences of sex development.将基因组学转化为性发育障碍/差异的临床诊断。
Curr Top Dev Biol. 2019;134:317-375. doi: 10.1016/bs.ctdb.2019.01.005. Epub 2019 Mar 20.
7
The Continuing Evolution of Ethical Standards for Genomic Sequencing in Clinical Care: Restoring Patient Choice.临床护理中基因组测序伦理标准的持续演变：恢复患者选择权。
J Law Med Ethics. 2017 Sep;45(3):333-340. doi: 10.1177/1073110517737531. Epub 2017 Oct 18.
8
Incidental or secondary findings: an integrative and patient-inclusive approach to the current debate.偶然或次要发现：当前争议的综合和患者包容方法。
Eur J Hum Genet. 2018 Oct;26(10):1424-1431. doi: 10.1038/s41431-018-0200-9. Epub 2018 Jul 3.
9
Next-generation sequencing approach for the diagnosis of human diseases: open challenges and new opportunities.用于人类疾病诊断的下一代测序方法：面临的公开挑战与新机遇。
EJIFCC. 2018 Apr 30;29(1):4-14. eCollection 2018 Apr.
10
A Next-Generation Sequencing Primer-How Does It Work and What Can It Do?新一代测序引物——它是如何工作的以及能做什么？
Acad Pathol. 2018 May 6;5:2374289518766521. doi: 10.1177/2374289518766521. eCollection 2018 Jan-Dec.
本文引用的文献
1
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing.ACMG 临床外显子组和基因组测序中偶然发现报告的推荐标准。
Genet Med. 2013 Jul;15(7):565-74. doi: 10.1038/gim.2013.73. Epub 2013 Jun 20.
2
Attitudes of African Americans toward return of results from exome and whole genome sequencing.非裔美国人对外显子组和全基因组测序结果回报的态度。
Am J Med Genet A. 2013 May;161A(5):1064-72. doi: 10.1002/ajmg.a.35914.
3
Informed Consent in Genome-Scale Research: What Do Prospective Participants Think?基因组规模研究中的知情同意：潜在参与者怎么看？
AJOB Prim Res. 2012 Jul 1;3(3):3-11. doi: 10.1080/21507716.2012.662575. Epub 2012 Jun 19.
4
A tiered-layered-staged model for informed consent in personal genome testing.知情同意的分层分级分期模型在个人基因组检测中的应用。
Eur J Hum Genet. 2013 Jun;21(6):596-601. doi: 10.1038/ejhg.2012.237. Epub 2012 Nov 21.
5
Women's experiences receiving abnormal prenatal chromosomal microarray testing results.女性接受异常产前染色体微阵列检测结果的体验。
Genet Med. 2013 Feb;15(2):139-45. doi: 10.1038/gim.2012.113. Epub 2012 Sep 6.
6
Barriers to genetic testing for breast cancer risk among ethnic minority women: an exploratory study.少数民族妇女乳腺癌风险基因检测障碍：一项探索性研究。
Ethn Dis. 2012 Summer;22(3):267-73.
7
Population studies: return of research results and incidental findings Policy Statement.人群研究：研究结果和偶然发现的回报政策声明。
Eur J Hum Genet. 2013 Mar;21(3):245-7. doi: 10.1038/ejhg.2012.152. Epub 2012 Jul 11.
8
Predictive genetic testing in minors for late-onset conditions: a chronological and analytical review of the ethical arguments.未成年者的迟发性疾病预测性基因检测：伦理论点的时间和分析性回顾。
J Med Ethics. 2012 Sep;38(9):519-24. doi: 10.1136/medethics-2011-100055. Epub 2012 Mar 8.
9
A brief historical and theoretical perspective on patient autonomy and medical decision making: Part I: The beneficence model.患者自主与医疗决策的简要历史与理论透视：第一部分：有利原则模式。
Chest. 2011 Mar;139(3):669-673. doi: 10.1378/chest.10-2532.
10
Participation in genetic testing research varies by social group.参与基因检测研究的情况因社会群体而异。
Public Health Genomics. 2011;14(2):85-93. doi: 10.1159/000294277. Epub 2010 Mar 18.
Zotero 插件